Pfizer seeks another ‘moonshot’ with $43 billion cancer deal

Pfizer said it will buy Seagen, a major push into cancer-fighting drugs as Pfizer remakes itself with financial windfall netted from its covid treatments.

View original article
Contributor: Daniel Gilbert